Home » News » World » BioNTech Boosts Its 2021 Vaccine Supply Forecast to 2 Billion Doses
1-MIN READ

BioNTech Boosts Its 2021 Vaccine Supply Forecast to 2 Billion Doses

Pfizer vaccine: For representation

Pfizer vaccine: For representation

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," said the company, referring to the additional dose that could be extracted from each vial of the vaccine.

German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” said the company, referring to the additional dose that could be extracted from each vial of the vaccine.

A new factory in Marburg, Germany, is also expected to open in February, and would help to ramp up its production capacity.

Read all the Latest News, Breaking News and Coronavirus News here

first published:January 11, 2021, 20:44 IST